Résultats de la recherche

  • Flux RSS
(1 - 20 of 27)

Pages

Hepatitis C virus infection and tight junction proteins: The ties that bind.
Single-cell genomics and spatial transcriptomics: discovery of novel cell states and cellular interactions in liver physiology and disease biology
Unravelling the importance of microRNAs during hepatitis C virus infection in the human liver.
Is minimally invasive true anatomical HCC resection a future way to improve results in bridge or salvage liver transplantation?
Perturbation of the circadian clock and pathogenesis of NAFLD.
The Nobel Prize in Medicine 2020 for the Discovery of Hepatitis C Virus: Transforming Hepatology.
Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis
Hepatitis C virus induces CD81 and claudin-1 endocytosis
Targeting Viral cccDNA for Cure of Chronic Hepatitis B
miR-122--a key factor and therapeutic target in liver disease.
Genetic variation in IL-10 influences the progression of hepatitis B infection.
Intraabdominal urokinase in the treatment of loculated infected ascites in cirrhosis.
Roadblocks and fast tracks: How RNA binding proteins affect the viral RNA journey in the cell.
Targeting the Host for New Therapeutic Perspectives in Hepatitis D
Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care.
Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced cytokines that inhibit hepatitis B virus production in primary human hepatocytes.
Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip.
Characterisation of endogenous Claudin-1 expression, motility and susceptibility to hepatitis C virus in CRISPR knock-in cells.

Pages

Islandora displays